First Trust Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-802,119
| Closed | -$81.5M | – | 2649 |
|
|
2025
Q4 | $81.5M | Sell |
802,119
-172,327
| -18% | -$13.8M | 0.06% | 397 |
|
|
2025
Q3 | $53.3M | Buy |
974,446
+244,516
| +33% | +$12.2M | 0.04% | 536 |
|
|
2025
Q2 | $38.8M | Sell |
729,930
-18,983
| -3% | -$964K | 0.03% | 671 |
|
|
2025
Q1 | $32.4M | Sell |
748,913
-53,854
| -7% | -$2.73M | 0.03% | 706 |
|
|
2024
Q4 | $45.1M | Sell |
802,767
-24,854
| -3% | -$1.55M | 0.04% | 567 |
|
|
2024
Q3 | $56.4M | Buy |
827,621
+318,710
| +63% | +$18M | 0.05% | 462 |
|
|
2024
Q2 | $21.5M | Sell |
508,911
-342,045
| -40% | -$18.8M | 0.02% | 765 |
|
|
2024
Q1 | $58.8M | Sell |
850,956
-41,668
| -5% | -$2.64M | 0.06% | 430 |
|
|
2023
Q4 | $66M | Sell |
892,624
-36,580
| -4% | -$2.4M | 0.07% | 368 |
|
|
2023
Q3 | $63.4M | Sell |
929,204
-351,592
| -27% | -$29.8M | 0.08% | 366 |
|
|
2023
Q2 | $120M | Sell |
1,280,796
-52,008
| -4% | -$4.06M | 0.14% | 181 |
|
|
2023
Q1 | $90.4M | Sell |
1,332,804
-8,825
| -0.7% | -$567K | 0.1% | 261 |
|
|
2022
Q4 | $66.4M | Buy |
1,341,629
+395,660
| +42% | +$16.2M | 0.08% | 386 |
|
|
2022
Q3 | $30.7M | Buy |
945,969
+251,091
| +36% | +$10.4M | 0.04% | 548 |
|
|
2022
Q2 | $27.4M | Sell |
694,878
-5,664
| -0.8% | -$303K | 0.03% | 597 |
|
|
2022
Q1 | $49M | Buy |
700,542
+99,441
| +17% | +$7.27M | 0.05% | 509 |
|
|
2021
Q4 | $46.8M | Buy |
601,101
+34,504
| +6% | +$3.05M | 0.05% | 520 |
|
|
2021
Q3 | $54.1M | Sell |
566,597
-210,861
| -27% | -$22.3M | 0.06% | 442 |
|
|
2021
Q2 | $96.6M | Sell |
777,458
-68,769
| -8% | -$8.21M | 0.1% | 245 |
|
|
2021
Q1 | $112M | Sell |
846,227
-197,111
| -19% | -$27M | 0.14% | 188 |
|
|
2020
Q4 | $138M | Buy |
1,043,338
+114,087
| +12% | +$13.8M | 0.18% | 138 |
|
|
2020
Q3 | $94.7M | Buy |
929,251
+51,629
| +6% | +$4.46M | 0.15% | 159 |
|
|
2020
Q2 | $76.3M | Buy |
877,622
+123,600
| +16% | +$9.88M | 0.13% | 190 |
|
|
2020
Q1 | $43.7M | Buy |
754,022
+179,725
| +31% | +$14.6M | 0.1% | 324 |
|
|
2019
Q4 | $53.1M | Sell |
574,297
-307,761
| -35% | -$27.1M | 0.09% | 326 |
|
|
2019
Q3 | $79.7M | Sell |
882,058
-653,722
| -43% | -$74.5M | 0.15% | 165 |
|
|
2019
Q2 | $181M | Buy |
1,535,780
+1,057,434
| +221% | +$107M | 0.34% | 40 |
|
|
2019
Q1 | $41.4M | Sell |
478,346
-290,299
| -38% | -$24.7M | 0.08% | 310 |
|
|
2018
Q4 | $48.5M | Buy |
768,645
+243,901
| +46% | +$16.7M | 0.12% | 217 |
|
|
2018
Q3 | $41.4M | Buy |
524,744
+516,442
| +6,221% | +$33.7M | 0.08% | 301 |
|
|
2018
Q2 | $496K | Sell |
8,302
-73,225
| -90% | -$3.94M | ﹤0.01% | 2156 |
|
|
2018
Q1 | $3.29M | Buy |
81,527
+3,199
| +4% | +$156K | 0.01% | 1187 |
|
|
2017
Q4 | $4.12M | Buy |
78,328
+9,630
| +14% | +$514K | 0.01% | 1092 |
|
|
2017
Q3 | $3.24M | Sell |
68,698
-33,959
| -33% | -$1.37M | 0.01% | 1196 |
|
|
2017
Q2 | $3.63M | Buy |
102,657
+54,121
| +112% | +$1.67M | 0.01% | 1146 |
|
|
2017
Q1 | $1.15M | Sell |
48,536
-45,545
| -48% | -$903K | ﹤0.01% | 1807 |
|
|
2016
Q4 | $1.26M | Buy |
+94,081
| New | +$1.52M | ﹤0.01% | 1723 |
|
|
2015
Q4 | – | Sell |
-4,669,070
| Closed | -$84M | – | 2258 |
|
|
2015
Q3 | $84M | Sell |
4,669,070
-195,494
| -4% | -$4.49M | 0.24% | 87 |
|
|
2015
Q2 | $145M | Buy |
4,864,564
+1,380,913
| +40% | +$34.7M | 0.38% | 39 |
|
|
2015
Q1 | $76.7M | Buy |
3,483,651
+868,313
| +33% | +$22M | 0.23% | 93 |
|
|
2014
Q4 | $71.8M | Sell |
2,615,338
-1,568,180
| -37% | -$38.2M | 0.24% | 80 |
|
|
2014
Q3 | $81.1M | Sell |
4,183,518
-307,786
| -7% | -$5.64M | 0.32% | 44 |
|
|
2014
Q2 | $76.5M | Buy |
4,491,304
+428,795
| +11% | +$5.9M | 0.32% | 37 |
|
|
2014
Q1 | $57.6M | Buy |
4,062,509
+138,092
| +4% | +$1.86M | 0.25% | 52 |
|
|
2013
Q4 | $46.1M | Buy |
3,924,417
+1,142,842
| +41% | +$13.1M | 0.22% | 73 |
|
|
2013
Q3 | $32.8M | Buy |
+2,781,575
| New | +$35.7M | 0.18% | 117 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
First Trust Advisors's EXAS Position: Q1 2026 in Review
First Trust Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 802,119 shares — an estimated $81.5M sold.
First Trust Advisors first reported a position in EXAS in Q3 2013 and held it in 46 quarters. The position peaked at $181M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- First Trust Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- First Trust Advisors sold 802,119 Exact Sciences shares in Q1 2026, an estimated $81.5M.
- First Trust Advisors first reported a position in Exact Sciences in Q3 2013 and held it in 46 quarters.
- First Trust Advisors's Exact Sciences position peaked at $181M in Q2 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.